文献速递心脑血管急症

有症状成人中冠状动脉斑块与低密度脂蛋白胆固醇水平及心血管事件率的关联

Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults.
PubMed 文献 · JAMA Netw Open · 2022-02-01
一句话结论有症状成人即使LDL-C≥190 mg/dL,冠状动脉CT血管造影无钙化和非钙化斑块者ASCVD事件率仍低(6.9/1000人年),提示斑块负荷可用于个体化治疗强度。

这项队列研究纳入2008年1月1日至2017年12月31日在半全国性西丹麦心脏登记处接受冠状动脉CT血管造影的有症状患者23143例,中位年龄58岁,女性55.6%,按LDL-C分层(<77、77-112、113-154、155-189、≥190 mg/dL)评估钙化与非钙化斑块患病率及其与心血管事件的关系。中位随访4.2年期间发生1029例ASCVD和死亡事件。所有LDL-C分层中无CAC均常见(≥190 mg/dL组46.2%,77-112 mg/dL组54.9%),且多数无斑块;无CAC者事件率低(6.3/1000人年),CAC 1-99为11.1/1000人年,CAC≥100为21.9/1000人年;CAC=0者各LDL-C分层事件率相似且低,≥190 mg/dL组为6.9/1000人年。作者认为,斑块负荷包括CAC可用于对LDL-C严重升高患者个体化治疗强度。

要点

  • 有症状成人中,无CAC在各LDL-C分层均常见:≥190 mg/dL组438/948(46.2%),77-112 mg/dL组4370/7964(54.9%)。
  • 无CAC者多数无斑块:≥190 mg/dL组338/438(77.2%),<77 mg/dL组1067/1204(88.6%)。
  • 所有LDL-C组中,无CAC者ASCVD和死亡率为6.3/1000人年(95%CI 5.6-7.0),CAC 1-99为11.1/1000人年(95%CI 10.0-12.5),CAC≥100为21.9/1000人年(95%CI 19.9-24.4)。
  • CAC=0者事件率总体为6.3/1000人年(95%CI 5.6-7.0),LDL-C≥190 mg/dL组为6.9/1000人年(95%CI 4.0-11.9)。
  • 各LDL-C分层中CAC=0者事件率相似且低,无论无斑块或仅有非钙化斑块。

适用人群与场景

  • 2008年1月1日至2017年12月31日在半全国性西丹麦心脏登记处接受冠状动脉CT血管造影的有症状患者,共23143例,中位年龄58岁(IQR 50-65),女性12857例(55.6%)。

诊断标准与关键阈值

  • 按LDL-C分层:<77、77-112、113-154、155-189、≥190 mg/dL。
  • 冠状动脉疾病严重程度按CAC评分分类:0、1-99、≥100,数值越高表示CAC负荷越大。

研究设计与关键结果

  • 研究设计:队列研究,纳入23143例有症状患者,来自半全国性西丹麦心脏登记处,中位随访4.2年(IQR 2.3-6.1),发生1029例ASCVD和死亡事件。
  • 无CAC患病率:≥190 mg/dL组438/948(46.2%),77-112 mg/dL组4370/7964(54.9%)。
  • 无CAC者无斑块比例:≥190 mg/dL组338/438(77.2%),<77 mg/dL组1067/1204(88.6%)。
  • 事件率:无CAC者6.3/1000人年(95%CI 5.6-7.0),CAC 1-99者11.1/1000人年(95%CI 10.0-12.5),CAC≥100者21.9/1000人年(95%CI 19.9-24.4)。
  • CAC=0者事件率:总体6.3/1000人年(95%CI 5.6-7.0),LDL-C≥190 mg/dL组6.9/1000人年(95%CI 4.0-11.9)。
  • 各LDL-C分层中CAC=0者事件率相似且低,无论无斑块或仅有非钙化斑块。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在LDL-C≥190 mg/dL、指南普遍视为高危的有症状患者中,冠状动脉CT血管造影无钙化和非钙化斑块与低ASCVD事件风险相关。
  • 作者进一步认为,斑块负荷包括CAC可用于对LDL-C严重升高患者个体化治疗强度。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Atherosclerosis burden and coronary artery calcium (CAC) are associated with the risk for atherosclerotic cardiovascular disease (ASCVD) events, with absence of plaque and CAC indicating low risk. Whether this is true in patients with elevated levels of low-density lipoprotein cholesterol (LDL-C) is not known. Specifically, a high prevalence of noncalcified plaque might signal high risk.

OBJECTIVE: To determine the prevalence of noncalcified and calcified plaque in symptomatic adults and assess its association with cardiovascular events across the LDL-C spectrum.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study included symptomatic patients undergoing coronary computed tomographic angiography from January 1, 2008, to December 31, 2017, from the seminational Western Denmark Heart Registry. Follow-up was completed on July 6, 2018. Data were analyzed from April 2 to December 2, 2021.

EXPOSURES: Prevalence of calcified and noncalcified plaque according to LDL-C strata of less than 77, 77 to 112, 113 to 154, 155 to 189, and at least 190 mg/dL. Severity of coronary artery disease was categorized using CAC scores of 0, 1 to 99, and ≥100, where higher numbers indicate greater CAC burden.

MAIN OUTCOMES AND MEASURES: Atherosclerotic cardiovascular disease events (myocardial infarction and stroke) and death.

RESULTS: A total of 23 143 patients with a median age of 58 (IQR, 50-65) years (12 857 [55.6%] women) were included in the analysis. During median follow-up of 4.2 (IQR, 2.3-6.1) years, 1029 ASCVD and death events occurred. Across all LDL-C strata, absence of CAC was a prevalent finding (ranging from 438 of 948 [46.2%] in patients with LDL-C levels of at least 190 mg/dL to 4370 of 7964 [54.9%] in patients with LDL-C levels of 77-112 mg/dL) and associated with no detectable plaque in most patients, ranging from 338 of 438 (77.2%) in those with LDL-C levels of at least 190 mg/dL to 1067 of 1204 (88.6%) in those with LDL-C levels of less than 77 mg/dL. In all LDL-C groups, absence of CAC was associated with low rates of ASCVD and death (6.3 [95% CI, 5.6-7.0] per 1000 person-years), with increasing rates in patients with CAC scores of 1 to 99 (11.1 [95% CI, 10.0-12.5] per 1000 person-years) and CAC scores of at least 100 (21.9 [95% CI, 19.9-24.4] per 1000 person-years). Among those with CAC scores of 0, the event rate per 1000 person-years was 6.3 (95% CI, 5.6-7.0) in the overall population compared with 6.9 (95% CI, 4.0-11.9) in those with LDL-C levels of at least 190 mg/dL. Across all LDL-C strata, rates were similar and low in those with CAC scores of 0, regardless of whether they had no plaque or purely noncalcified plaque.

CONCLUSIONS AND RELEVANCE: The findings of this cohort study suggest that in symptomatic patients with severely elevated LDL-C levels of at least 190 mg/dL who are universally considered to be at high risk by guidelines, absence of calcified and noncalcified plaque on coronary computed tomographic angiography was associated with low risk for ASCVD events. These results further suggest that atherosclerosis burden, including CAC, can be used to individualize treatment intensity in patients with severely elevated LDL-C levels.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Mortensen MB, Caínzos-Achirica M, Steffensen FH, et al. Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults. JAMA Netw Open. 2022. PMID: 35147685. doi:10.1001/jamanetworkopen.2021.48139

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。